Since NPM1 depletion also sensitizes glioma cells to Act D it might be suggested that this is due to accumulated targeting of DNA integrity rather than a specific loss of function as a consequence of a lost NPM1-H1.5 interaction, this remains to be determined. This evidence concerns the gene NPM1 and central nervous system cancer.